Viewing Study NCT00002420


Ignite Creation Date: 2025-12-25 @ 4:09 AM
Ignite Modification Date: 2026-02-25 @ 5:20 AM
Study NCT ID: NCT00002420
Status: TERMINATED
Last Update Posted: 2008-08-14
First Post: 1999-11-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
Sponsor:
Organization: